Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

Phase: N/A Priority: Normal
NCT ID: NCT06071949 Org: User:
Start: 11/02/23 End: 12/31/24 Due: 12/31/25

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

Phase: N/A Priority: Normal
NCT ID: NCT06072001 Org: User:
Start: 11/02/23 End: 12/31/24 Due: 12/31/25

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT06071962 Org: User:
Start: 11/02/23 End: 12/31/24 Due: 12/31/25

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06071975 Org: User:
Start: 11/02/23 End: 12/31/24 Due: 12/31/25

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06072573 Org: User:
Start: 11/02/23 End: 12/31/24 Due: 12/31/25

Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06071988 Org: User:
Start: 11/02/23 End: 12/31/24 Due: 12/31/25

Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06071936 Org: User:
Start: 11/02/23 End: 12/31/24 Due: 12/31/25

Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT06072560 Org: User:
Start: 11/02/23 End: 12/31/24 Due: 12/31/25